List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #8,651 to #8,700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. C3 renal disease → C3 glomerulopathy
  2. C3 renal disorder → C3 glomerulopathy
  3. C4 disease → C4 glomerulopathy
  4. C4 glomerular disease → C4 glomerulopathy
  5. C4 glomerulonephritis → C4 glomerulopathy
  6. C4 nephritis → C4 glomerulopathy
  7. C4 nephropathy → C4 glomerulopathy
  8. C4 photosynthesis → C4 carbon fixation
  9. C4 renal disease → C4 glomerulopathy
  10. C4 renal disorder → C4 glomerulopathy
  11. C4b → Complement component 4
  12. C5b → Complement component 5
  13. CA-125 test → CA-125
  14. CA1 → Hippocampus anatomy
  15. CA125 → CA-125
  16. CA19-9 → CA 19-9
  17. CABG → Coronary artery bypass surgery
  18. CABG PATCH → The Coronary Artery Bypass Graft Patch Trial
  19. CABG Patch Cardioplegia Substudy → Does Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria
  20. CABRI → Coronary Angioplasty Versus Bypass Revascularization Investigation
  21. CACAF → Catheter Ablation For The Cure Of Atrial Fibrillation Study
  22. CACH → Leukoencephalopathy with vanishing white matter
  23. CACHET → Comparison Of Abciximab Complications With Hirulog (Angiomax As Of 1999) Ischemic Events Trial
  24. CACNA1A → Cav2.1
  25. CACNA1c → CACNA1C
  26. CACTUS → Coronary Bifurcations: Application Of The Crushing Technique Using Sirolimus-Eluting Stents
  27. CAC score → Coronary artery calcium scoring
  28. CAC scoring → Coronary artery calcium scoring
  29. CAD → Coronary heart disease
  30. CADILLAC → Controlled Abciximab (Reopro) And Device Investigation To Lower Late Angioplasty Complications
  31. CAD prevention → Coronary heart disease prevention
  32. CAD risk factors → Coronary heart disease risk factors
  33. CAD risk stratification → Coronary heart disease risk stratification
  34. CAE → Childhood absence epilepsy
  35. CAESAR → Canada, Australia, Europe, South Africa Aids Study
  36. CAF → Coronary artery fistula
  37. CAFA → Canadian Atrial Fibrillation Anticoagulation Study
  38. CAFE → Conduit Artery Function Evaluation
  39. CAH → Congenital adrenal hyperplasia
  40. CAH1 → 21-hydroxylase deficiency
  41. CAH 1 → 21-hydroxylase deficiency
  42. CAH due to 21-hydroxylase deficiency → 21-hydroxylase deficiency
  43. CAH type 1 → 21-hydroxylase deficiency
  44. CAKE (drug) → Brass Eye
  45. CAL → Café au lait spot
  46. CALM → Candesartan And Lisinopril Microalbuminuria Study
  47. CALM-PD → Comparison Of The Agonist Pramipexole Vs. Levodopa On Motor Complications In Parkinson Disease
  48. CALYPSO → Cylexin As An Adjunct To Lytic Therapy To Prevent Superoxide Reflow Injury
  49. CAMAK syndrome → CAMFAK syndrome
  50. CAMELOT → Comparison Of Amlodipine Versus Enalapril (Lipitor) To Limit Occurrences Of Thrombosis

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"